These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1267887)

  • 1. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular effects of enflurane, alone and combined with d-Tubocurarine, pancuronium, and succinylcholine, in man.
    Fogdall RP; Miller RD
    Anesthesiology; 1975 Feb; 42(2):173-8. PubMed ID: 1115366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of halothane on tubocurarine and suxamethonium block in man.
    Baraka A
    Br J Anaesth; 1968 Aug; 40(8):602-6. PubMed ID: 5243759
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction between d-tubocurarine, pancuronium, polymyxin B, and neostigmine on neuromuscular function.
    Van Nyhuis LS; Miller RD; Fogdall RP
    Anesth Analg; 1976; 55(2):224-8. PubMed ID: 176904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of d-tubocurarine priming on an ED95 dose of vecuronium bromide.
    Miguel RV; Barlow IK; Dombrowski DL
    J Clin Anesth; 1994; 6(2):106-9. PubMed ID: 7911306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulus frequency and dose-respone curve to d-tubocurarine in man.
    Ali HH; Savarese JJ
    Anesthesiology; 1980 Jan; 52(1):36-9. PubMed ID: 7352643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man.
    Katz RL; Gissen AJ
    Anesthesiology; 1967; 28(3):564-7. PubMed ID: 4225766
    [No Abstract]   [Full Text] [Related]  

  • 8. Metocurine in infants and children: neuromuscular and clinical effects.
    Goudsouzian NG; Liu LM; Savarese JJ
    Anesthesiology; 1978 Oct; 49(4):266-9. PubMed ID: 697081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in dose requirement of d-tubocurarine by volatile anesthetics.
    Waud BE
    Anesthesiology; 1979 Oct; 51(4):298-302. PubMed ID: 39476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of neuromuscular transmission. The effect of succinylcholine chloride on phase II block, with special reference to the effect of a small amount of d-tubocurarine on preparalytic facilitation].
    Kuze S; Murakami S
    Masui; 1973 Mar; 22(3):208-17. PubMed ID: 4354482
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of prostaglandins and indomethacin on neuromuscular blocking agents.
    Hill GE; Wong KC
    Can Anaesth Soc J; 1980 Mar; 27(2):146-9. PubMed ID: 7363143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of dosage and duration of action of d-tubocurarine in the pediatric age group.
    Goudsouzian NG; Donlon JV; Savarese JJ; Ryan JF
    Anesthesiology; 1975 Oct; 43(4):416-25. PubMed ID: 170845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulation of neomycin and its residual potentiation of tubocurarine in the cat.
    Durant NN; Lee C; Katz RL
    Br J Anaesth; 1981 Jun; 53(6):571-6. PubMed ID: 7248120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The onset of alcuronium and tubocurarine: alone and in combination.
    Roberts SP; Pollard BJ
    Acta Anaesthesiol Scand; 1993 Feb; 37(2):195-8. PubMed ID: 8383403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autonomic margins of safety of metocurine and d-tubocurarine in the cat.
    Savarese JJ
    Anesthesiology; 1979 Jan; 50(1):40-6. PubMed ID: 83803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of small incremental doses of d-tubocurarine on neuromuscular transmission in anesthetized man.
    Heisterkamp DV; Skovsted P; Cohen PJ
    Anesthesiology; 1969 May; 30(5):500-5. PubMed ID: 4305093
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison in vitro of isoflurane and halothane potentiation of d-tubocurarine and succinylcholine neuromuscular blockades.
    Vitez TS; Miller RD; Eger EI; Van Nyhuis LS; Way WL
    Anesthesiology; 1974 Jul; 41(1):53-6. PubMed ID: 4834378
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular effects of succinylcholine following different pretreatments.
    McLoughlin CC; Mirakhur RK; McCarthy GJ
    J Clin Anesth; 1993; 5(1):50-3. PubMed ID: 8442969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of d-tubocurarine in man with and without renal failure.
    Miller RD; Matteo RS; Benet LZ; Sohn YJ
    J Pharmacol Exp Ther; 1977 Jul; 202(1):1-7. PubMed ID: 195035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.